Pressure-enabled Delivery in Radioembolization (TriNav Study)
NCT: NCT05128032 · COMPLETED
Brief Summary
The purpose of the study is to determine if the type of catheter used in the mapping procedure prior to radioembolization improves the delivery of radioactivity to tumor(s) in participants with liver cancer. The name of the devices involved in this study are: * Pressure Enabled Drug Delivery (PEDD)/TriNav Infusion System * Standard 2.4F microcatheter, not otherwise specified
Frequently Asked Questions
What is Pressure-enabled Delivery in Radioembolization (TriNav Study)?
Pressure-enabled Delivery in Radioembolization (TriNav Study) is a clinical trial registered under NCT05128032. Current status: COMPLETED.
What is the status of NCT05128032?
The current status of NCT05128032 (Pressure-enabled Delivery in Radioembolization (TriNav Study)) is: COMPLETED.
When did Pressure-enabled Delivery in Radioembolization (TriNav Study) start?
Pressure-enabled Delivery in Radioembolization (TriNav Study) started on 2022-03-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.